• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

How did the webcasts go?

Quote
























anonymous said:
Not to mention the waste of $. How much did Sun drop on PA webcast?
Click to expand...

Enough with cramming these programs into a short window! Derms will just send staff for free meal and ones that attend speak for other companies and only want intel. Spread programs out to 2019! We are bullied by our RSMs to have these programs. Running around recruiting for subpar program when we should be out promoting drug and fixing Hub! Feedback was not a great first broadcast at all for our first biologic in this market. Speakers did not seem excited. Why didn’t anyone ask how many patients do you have on drug?
 




Sunburned said:
Enough with cramming these programs into a short window! Derms will just send staff for free meal and ones that attend speak for other companies and only want intel. Spread programs out to 2019! We are bullied by our RSMs to have these programs. Running around recruiting for subpar program when we should be out promoting drug and fixing Hub! Feedback was not a great first broadcast at all for our first biologic in this market. Speakers did not seem excited. Why didn’t anyone ask how many patients do you have on drug?
Click to expand...

Some RSM's were pushing their TM's to just put any attendees in the system to keep the programs from cancelling. It seemed they would rather lie than explain to to their manager that they had no one coming. The true attendance was pathetic.
 




Top Bottom
Back
Quote